BR112014014671A2 - processo para produzir fator de transferência e produto - Google Patents

processo para produzir fator de transferência e produto

Info

Publication number
BR112014014671A2
BR112014014671A2 BR112014014671A BR112014014671A BR112014014671A2 BR 112014014671 A2 BR112014014671 A2 BR 112014014671A2 BR 112014014671 A BR112014014671 A BR 112014014671A BR 112014014671 A BR112014014671 A BR 112014014671A BR 112014014671 A2 BR112014014671 A2 BR 112014014671A2
Authority
BR
Brazil
Prior art keywords
product
transfer factor
produce transfer
produce
factor
Prior art date
Application number
BR112014014671A
Other languages
English (en)
Other versions
BR112014014671B1 (pt
Inventor
Citlati Elvira Estrada-García Iris
Estrada-Parra Sergio
Mayra Pérez-Tapia Sonia
Original Assignee
Inst Politecnico Nacional
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Politecnico Nacional filed Critical Inst Politecnico Nacional
Publication of BR112014014671A2 publication Critical patent/BR112014014671A2/pt
Publication of BR112014014671B1 publication Critical patent/BR112014014671B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
BR112014014671-3A 2011-12-16 2012-12-17 Processo para produzir um fator de transferência e produto BR112014014671B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MXMX/A/2011/013852 2011-12-16
MX2011013852A MX338863B (es) 2011-12-16 2011-12-16 Metodo de obtencion de extracto dializable de leucocitos.
PCT/MX2012/000129 WO2013089550A1 (es) 2011-12-16 2012-12-17 Método de obtención de extracto dializable de leucocitos

Publications (2)

Publication Number Publication Date
BR112014014671A2 true BR112014014671A2 (pt) 2017-06-13
BR112014014671B1 BR112014014671B1 (pt) 2022-05-10

Family

ID=48612894

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014671-3A BR112014014671B1 (pt) 2011-12-16 2012-12-17 Processo para produzir um fator de transferência e produto

Country Status (20)

Country Link
US (1) US9328152B2 (pt)
EP (1) EP2792685B1 (pt)
BR (1) BR112014014671B1 (pt)
CA (1) CA2860260C (pt)
CL (1) CL2014001584A1 (pt)
CO (1) CO7230340A2 (pt)
CY (1) CY1121260T1 (pt)
DK (1) DK2792685T3 (pt)
ES (1) ES2688318T3 (pt)
GT (1) GT201400117A (pt)
HR (1) HRP20181501T1 (pt)
HU (1) HUE039451T2 (pt)
LT (1) LT2792685T (pt)
MX (1) MX338863B (pt)
PE (1) PE20141566A1 (pt)
PL (1) PL2792685T3 (pt)
PT (1) PT2792685T (pt)
RS (1) RS57821B1 (pt)
SI (1) SI2792685T1 (pt)
WO (1) WO2013089550A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108129549B (zh) * 2017-12-19 2020-06-05 浙江丰安生物制药有限公司 一种脾氨肽内多肽的提取方法
WO2022123298A1 (es) * 2020-12-09 2022-06-16 Instituto Politecnico Nacional Composición de péptidos para inmunoterapia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
DE3244607A1 (de) 1982-12-02 1984-06-07 Bezirksblutspendezentrale Plauen, DDR 9900 Plauen Verfahren zur herstellung von humanen transfer-faktor-praeparaten
US4816563A (en) 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
EP0225254B1 (en) 1985-11-25 1994-03-16 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
EP0537280B1 (en) * 1990-07-02 1997-09-17 National Jewish Center For Immunology And Respiratory Medicine Preparation and use of transfer factor
MX9504215A (es) * 1995-10-05 1997-04-30 Inst Politecnico Nacional Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.
US5883224A (en) * 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
US20020044942A1 (en) * 2000-09-18 2002-04-18 Chisolm Biological Laboratory, Llc Transfer factor composition and process for producing same
US6468534B1 (en) 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
US10471100B2 (en) * 2006-09-29 2019-11-12 4Life Patents, Llc Nanofraction immune modulators, preparations and compositions including the same, and associated methods
CZ299296B6 (cs) * 2006-06-13 2008-06-11 Sevapharma A.S. Lécivo transfer faktor - zpusob výroby a použití

Also Published As

Publication number Publication date
CA2860260C (en) 2019-02-12
BR112014014671B1 (pt) 2022-05-10
MX2011013852A (es) 2013-09-05
CO7230340A2 (es) 2015-03-31
HUE039451T2 (hu) 2018-12-28
PT2792685T (pt) 2018-10-26
SI2792685T1 (sl) 2018-11-30
US20140357840A1 (en) 2014-12-04
WO2013089550A1 (es) 2013-06-20
HRP20181501T1 (hr) 2018-11-16
PL2792685T3 (pl) 2019-03-29
MX338863B (es) 2016-05-01
PE20141566A1 (es) 2014-11-26
RS57821B1 (sr) 2018-12-31
GT201400117A (es) 2019-08-02
ES2688318T3 (es) 2018-10-31
EP2792685A1 (en) 2014-10-22
US9328152B2 (en) 2016-05-03
CA2860260A1 (en) 2013-06-20
EP2792685A4 (en) 2015-05-06
EP2792685B1 (en) 2018-06-27
LT2792685T (lt) 2018-10-25
CL2014001584A1 (es) 2015-04-24
CY1121260T1 (el) 2020-05-29
DK2792685T3 (en) 2018-10-08

Similar Documents

Publication Publication Date Title
BR112014005322A2 (pt) processo
BR112013014814A2 (pt) processo para produzir ácido acético
BR112013000370A2 (pt) artigo orientado e processo para formar um artigo orientado
BR112012026904A2 (pt) processo para produção de sorvete
BR112014016000A2 (pt) processo
BR112013025814A2 (pt) composição e processo
BR112013014846A2 (pt) processo para produzir macarrão instantâneo
BR112014012414A8 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112014005428A2 (pt) produto de chocolate e processo para produção do mesmo
BR112013033532A2 (pt) corante cristalino natural e processo para produzi-lo
BR112013016365A2 (pt) composição de lipossoma e processo para produção do mesmo
BR112014016001A8 (pt) processo
BR112013022327A2 (pt) processo para hidrogenar nitrilas
BR112014015988A8 (pt) processo
BR112013013142A2 (pt) processo para produzir partículas de poliamida
BR112013033184A2 (pt) processo
BR112012009097A2 (pt) processo para produzir colagens
BR112014010997A2 (pt) processo para o preparo de ß-glicosídeos de c-arila
BR112014015229A8 (pt) processo de transformação aromática
BR112012029244A2 (pt) processo para produzir tdae-1 ou tdae-2 e produto tdae-1 ou tdae-2
BR112014015999A8 (pt) processo
BR112013014949A2 (pt) processo para produção de proteína
BR112014004588A2 (pt) processo de preparação da l-metionina
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112014014052A2 (pt) processo para a preparação de 5-hidroximetilfurfural

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/12/2012, OBSERVADAS AS CONDICOES LEGAIS